ReviewGynecologic oncology reports2026
A comprehensive model for gynecologic cancer patients' survivorship care.
Review in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Objectives: The population of gynecologic cancer survivors is rapidly increasing, yet survivorship care remains fragmented and often focused primarily on surveillance for disease recurrence. This review aims to define the key domains shaping survivorship and propose a comprehensive, patient-centered model for gynecologic oncology. Methods: Our narrative reviews and synthesizes current evidence and clinical perspectives to examine gynecologic cancer survivorship. We organize the analysis around four clinically relevant pillars: menopause management, sexual health and function, psychosocial health, and nutrition and physical activity. Evidence was summarized and gaps in care are identified to inform a comprehensive survivorship framework. Results: Gynecologic cancer survivors experience complex and interrelated long-term sequelae. Treatment-induced menopause contributes to substantial symptom burden and increased risk of chronic disease. Sexual dysfunction is highly prevalent yet frequently underrecognized in clinical care. Psychosocial challenges, including depression, anxiety, fear of recurrence, and financial toxicity, are common and persistent. Nutrition and physical activity influence quality of life, physical functioning, and survival outcomes, although gynecologic cancer-specific evidence remains limited. Deficiencies in routine screening and assessment across survivorship domains, clinician knowledge and training, and access to multidisciplinary interventions contribute to unmet survivorship needs. Conclusions: Survivorship care in gynecologic oncology requires a structured, holistic, and multidisciplinary approach that extends beyond surveillance for disease recurrence. Integrating menopause care, sexual health support, psychosocial services, and lifestyle interventions into routine care is essential to address unmet needs and improve long-term outcomes. A comprehensive model centered on these four pillars provides a practical framework for screening, intervention, and multidisciplinary survivorship care aimed at improving long-term quality of life and health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.